Ways to bypass a blocked tenase complex.
Tuddenham
Edward G D
EG
D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology / Q000627:therapeutic use; D001323:Autoantibodies / Q000097:blood; D001777:Blood Coagulation / Q000187:drug effects; D003546:Cysteine Endopeptidases / Q000276:immunology*; D015949:Factor IXa / Q000276:immunology*; D015944:Factor VIIIa / Q000276:immunology*; D006467:Hemophilia A / Q000097:blood / Q000188:drug therapy; D006801:Humans; D008074:Lipoproteins / Q000037:antagonists & inhibitors; D051379:Mice; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors / Q000276:immunology*; D010426:Pentosan Sulfuric Polyester / Q000494:pharmacology / Q000627:therapeutic use; D011134:Polysaccharides / Q000494:pharmacology / Q000627:therapeutic use
D000925:Anticoagulants; D001323:Autoantibodies; D008074:Lipoproteins; D009363:Neoplasm Proteins; D011134:Polysaccharides; C051928:lipoprotein-associated coagulation inhibitor; D010426:Pentosan Sulfuric Polyester; D015944:Factor VIIIa; C007789:fucoidan; D015949:Factor IXa; D003546:Cysteine Endopeptidases; C030910:cancer procoagulant